This review comprehensively describes recent advances in the management of malignant
central airway obstruction (CAO). Malignant CAO can be a dramatic and devastating …

Malignant central airway obstruction (MCAO) is an important manifestation of advanced
primary lung cancer or metastatic disease and has a significant impact on both morbidity …

Background: Although interventional management of malignant central airway obstruction
(mCAO) is well established, its impact on survival and quality of life (QoL) has not been …

Introduction Central airway obstruction (CAO) is a life-threatening complication of lung
cancer. The prevalence of CAO in lung cancer patients is unknown. We audited CAO burden …

Background: Central airway obstruction (CAO) occurs in patients with primary or metastatic
lung malignancy and nonmalignant pulmonary disorders and results in significant adverse …

Malignant central airway obstruction produces progressive symptoms of dyspnea, stridor,
and obstructive pneumonia. The nature and degree of symptoms depend on the location …

Benign central airway obstruction (CAO) is responsible for significant morbidity due to
dyspnea and impaired quality of life. While iatrogenic causes, including stenosis after …

Central airway obstruction is a problem facing all medical and surgical subspecialists caring
for patients with chest diseases. The incidence of this disorder appears to be rising because …

Lung cancer is the most common cause of cancer death in Australia, Europe and the USA.
Up to 20–30% of these cancers eventually affect the central airways and result in reduced …

Introduction Central airway obstruction (CAO) represents a pathological condition that can
lead to airflow limitation of the trachea, main stem bronchi, bronchus intermedius or lobar …